Ning Pan

Ning Pan is a Director at Decibel Therapeutics, a biotechnology company focused on developing treatments for hearing disorders.1 Here's an overview of Ning Pan's professional background:

Career Progression

Ning Pan has been with Decibel Therapeutics since May 2016, advancing through several roles:

• Director (December 2020 - Present)
• Associate Director (November 2019 - December 2020)
• Senior Scientist (May 2016 - November 2019)1

Prior to joining Decibel Therapeutics, Ning Pan held academic research positions:

• Associate Research Scientist at the University of Iowa (March 2009 - May 2016)
• Research Associate at the University of Colorado at Boulder (May 2005 - March 2009)1

Education

Ning Pan has a strong educational background in biology and genetics:

• Ph.D. in Molecular, Cellular and Developmental Biology from the University of Colorado Boulder (1999 - 2005)
• M.S. in Cell Biology and Genetics from Peking University (1996 - 1999)
• B.S. in Biology from Peking University (1991 - 1996)1

Expertise

Ning Pan's experience spans both academic and pharmaceutical research, with expertise in:

• Molecular biology
• Genetics
• Cellular research
• Biotechnology

At Decibel Therapeutics, Ning Pan is involved in the company's mission to discover and develop medicines for hearing conditions.2 Their work contributes to the field of hearing therapeutics, including potential gene therapy programs for congenital, monogenic hearing loss.3